drugset / Trial / NCT06105658
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
NaSingle-groupOpen-labelTreatment
Summary
This study aimed to evaluate the safety and efficacy of unrelated umbilical cord blood microtransplantation in the treatment of AML patients by observing the factors related to the efficacy and adverse reactions.
Timeline
- Start
- 2023-10
- Primary completion
- 2024-02-01
- Completion
- 2026-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Unrelated Umbilical Cord Blood | Cell therapy | — | — |
| Background | Azacitidine | Other / unclassified | 75 mg/m2 | — |
| Background | Decetabine | Unknown | 20 mg/m2 | — |
| Background | Venetoclax | Small molecule | 400 mg | — |